Nephros (NEPH) Other financing activities (2011 - 2026)

Nephros (NEPH) posted quarterly Other financing activities of $290000.0 for Q1 2026, up 1260.0% quarter-over-quarter from -$25000.0 in Q3 2022.

Nephros (NEPH) Other financing activities (2011 - 2026) Analysis & Trends

Nephros' Other financing activities history runs 11 years deep, the most recent figure standing at $290000.0 for Q1 2026.

In Q1 2026, Other financing activities changed N/A year-over-year to $290000.0; the TTM figure through Mar 2026 stood at $265000.0 (changed N/A YoY), while the FY2022 annual figure was $163000.0, down 20.1% from the prior year.
Other financing activities for Q1 2026 stood at $290000.0, up from -$25000.0 in the prior quarter.
The five-year high for Other financing activities was $290000.0 in Q1 2026, with the low at -$25000.0 in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	134.93 Bn	129.72 Bn	1.96 Bn
2	Becton Dickinson	52.43 Bn	51.56 Bn	2.32 Bn
3	Alcon	35.83 Bn	34.48 Bn	1.68 Bn
4	Resmed	33.87 Bn	32.40 Bn	861.22 Mn
5	Medline	28.86 Bn	26.18 Bn	2.22 Bn
6	West Pharmaceutical Services	25.04 Bn	24.60 Bn	329.20 Mn
7	Solventum	15.34 Bn	14.94 Bn	1.29 Bn
8	Cooper Companies	14.89 Bn	14.75 Bn	735.40 Mn
9	Baxter International	13.65 Bn	11.50 Bn	1.03 Bn
10	Nephros	46.70 Mn	42.00 Mn	4.03 Mn

Download Data